News and Analysis

The drug-resistant and deadly fungus Candida auris has proven hard to stamp out in 2026. Despite efforts to contain its spread, the fungus is once

Health tech companies made several major funding announcements in July. Here is a list of some of the biggest funding rounds. The post 4 Notable

Intravenous (IV) fluid therapy is a complex, high-risk clinical intervention and requires ongoing decision-making throughout the patient journey. This guidance, published by the Australian Commission

The future of value-based care will hinge on empowering providers, and specialists in particular, with the data and strategic partnerships to proactively manage patient health